13.07.2015 Views

2008 Legislative Impact of JLARC Studies - Virginia Joint Legislative ...

2008 Legislative Impact of JLARC Studies - Virginia Joint Legislative ...

2008 Legislative Impact of JLARC Studies - Virginia Joint Legislative ...

SHOW MORE
SHOW LESS
  • No tags were found...

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

since July 1, 2007. The Chairman desired that <strong>JLARC</strong> staff assessany possible effects that the fees may have had on driving behaviorand State revenues, and to also include information on the effects<strong>of</strong> similar fees in other states.The study reached four main conclusions. First, a great deal <strong>of</strong> uncertaintyexisted among law enforcement <strong>of</strong>ficers and judges regardingwhich <strong>of</strong>fenses were subject to the fees. Second, data onarrest rates showed that the fees did not have a discernible deterrenteffect upon driving behavior. Third, revenue projections werebased on some uncertain assumptions and the original estimate <strong>of</strong>$65 million in annual revenues could be <strong>of</strong>f by as much as $28 millionin either direction. Fourth, because the penalty for nonpaymentwas suspension <strong>of</strong> driving privileges, more than 300,000suspension orders could be issued to <strong>Virginia</strong> drivers in the firsttwo years after the fees were imposed.Actions by the <strong>2008</strong> General Assembly• Senate Bill 1 (Houck) and House Bill 1243 (Hugo) repealedthe abusive driver fees.EVALUATIONS OF PROPOSED MANDATEDHEALTH INSURANCE BENEFITSThe Code <strong>of</strong> <strong>Virginia</strong> requires <strong>JLARC</strong> to provide staff assistance tothe Special Advisory Commission on Mandated Health InsuranceBenefits. <strong>JLARC</strong> staff are to evaluate the social and economic costsand benefits <strong>of</strong> proposed health insurance mandates. In 2007,<strong>JLARC</strong> staff evaluated three proposed mandates requiring coverage<strong>of</strong> the human papillomavirus (HPV) vaccine, second opinionsfor primary malignant brain tumor patients at NCI ComprehensiveCancer Centers, and prosthetic devices. <strong>JLARC</strong> staff alsoevaluated two proposals to repeal the mandated <strong>of</strong>fer for high-dosechemotherapy (HDC) with an autologous bone marrow transplant(ABMT) or stem cell transplant (SCT) for breast cancer.The <strong>JLARC</strong> staff evaluations found evidence to support the mandateproposals in two areas. The prosthetics mandate is consistentwith the role <strong>of</strong> health insurance and would establish a minimumlevel <strong>of</strong> coverage for individuals requiring prostheses. The repeal <strong>of</strong>the HDC-ABMT/SCT mandate is appropriate because recent researchhas determined that HDC-ABMT/SCT provides no additionalbenefit over conventional chemotherapy and is rarely usedin the treatment <strong>of</strong> breast cancer.The <strong>JLARC</strong> staff evaluations concluded that neither the proposedHPV mandate nor the second opinions mandate is necessary.<strong>Impact</strong> <strong>of</strong> <strong>JLARC</strong> <strong>Studies</strong>, May <strong>2008</strong> 5

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!